TO: Honorable Mayor and Members of the City Council
THRU: Tom Kisela, City Manager
FROM: Adam Jevec, Chief of Police
1. SUBJECT
title
Authorize purchase of opioid trauma kits for the Police Department from High Threat Innovations, LLC as a sole source vendor.
body
2. SUMMARY
Purchase of 230 opioid trauma kits from High Threat Innovations, LLC of Rancho Cucamonga, California as a sole source vendor. The total amount of $50,912 includes custom opioid trauma kits designed specifically for first responders to support remediation activities in the City of Orange.
3. RECOMMENDED ACTION
recommendation
1. Approve the sole source purchase of opioid trauma kits from High Threat Innovations, LLC for $50,912.
2. Authorize the appropriation of $50,912 from the Opioid Settlement Fund (126) unreserved fund balance to: 126.4011.53940.00000 Safety Equipment
end
4. FISCAL IMPACT
Upon approval of this appropriation, the estimated Opioid Settlement Fund (126) fund balance at June 30, 2025, will be $1 million.
5. STRATEGIC PLAN GOALS
Goal 1: Maintain Strong Emergency and Safety Services
6. DISCUSSION AND BACKGROUND
In 2022, California Attorney General Rob Bonta announced settlement agreements with opioid manufacturer Janssen Pharmaceuticals and Johnson & Johnson, along with distributors McKesson, Cardinal Health, and AmerisourceBergen. In 2023, he proposed multistate settlements with manufacturers Teva and Allergan, and pharmacies Walgreens, Walmart, and CVS. These settlements resolve over 3,000 opioid-related lawsuits from state and local governments nationwide, providing substantial financial resources to combat the opioid crisis in California.
California cities and counties are expected to receive up to $1.8 billion for substance use prevention, harm reduction, treatment, and recovery from the settlements with Teva, Allergan, and the Pharmacies, in addition to $2.2 billion anticipated from the Janssen and Distributors settlements. Payment timeframes may vary...
Click here for full text